Showing results (91-100 of 140) with videos related to
Sort By:
Pageof 14
JTO Clinical and Research Reports|October 13, 2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLCSun Min Lim, Ana Laura Ortega Granados, Gustavo Dix Junqueira Pinto, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerSun Min Lim, Woong Youn Chung, Kee-Hyun Nam, et al.Translational Lung Cancer Research|March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancerShinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.Molecular Cancer Therapeutics|May 20, 2016
EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell LinesSung-Moo Kim, Hwan Kim, Kang Won Jang, et al.Cancer Research and Treatment|August 22, 2014
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and ChildrenSun Min Lim, Cheol Joo Yoo, Jung Woo Han, et al.Plos One|February 23, 2024
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturingSeul Lee, Yunjoo Joo, Eun Ji Lee, et al.Nature Communications|November 11, 2023
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trialSun Min Lim, Solange Peters, Ana Laura Ortega Granados, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2016
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung CancerKyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLCEun Ji Lee, Seung Yeon Oh, You Won Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung AdenocarcinomaSeok-Young Kim, Sang-Min Kim, Sumin Lim, et al.Pageof 14